Addison Advisors’s Moderna MRNA Stock Holding History

Addison Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$610	Hold	12	–	–	﹤0.01%	917
2025 Q4	$354	Hold	12	–	–	﹤0.01%	871
2025 Q3	$310	Hold	12	–	–	﹤0.01%	864
2025 Q2	$332	Hold	12	–	–	﹤0.01%	852
2025 Q1	$341	Sell	12 -13	-52%	-$461	﹤0.01%	810
2024 Q4	$1.04K	Hold	25	–	–	﹤0.01%	785
2024 Q3	$1.67K	Sell	25 -25	-50%	-$2.29K	﹤0.01%	748
2024 Q2	$5.94K	Hold	50	–	–	﹤0.01%	614
2024 Q1	$5.33K	Hold	50	–	–	﹤0.01%	562
2023 Q4	$4.97K	Hold	50	–	–	﹤0.01%	573
2023 Q3	$5.17K	Hold	50	–	–	﹤0.01%	542
2023 Q2	$6.08K	Sell	50 -69	-58%	-$9.21K	﹤0.01%	520
2023 Q1	$18.3K	Sell	119 -3	-2%	-$495	0.01%	408
2022 Q4	$21.9K	Sell	122 -3	-2%	-$491	0.01%	368
2022 Q3	$15K	Hold	125	–	–	0.01%	391
2022 Q2	$18K	Buy	125 +6	+5%	+$858	0.01%	369
2022 Q1	$20K	Sell	119 -49	-29%	-$8.25K	0.01%	395
2021 Q4	$43K	Buy	+168	New	+$49.1K	0.03%	259

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return